Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,276
archived clinical trials in
Pancreatic Cancer

An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer
A Phase 2 Randomized, Placebo-controlled, Double-blind Study of the Efficacy of MORAb-009 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer.
Status: Enrolling
Updated:  9/4/2015
Carle Clinic Assoc.
mi
from
Urbana, IL
An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer
A Phase 2 Randomized, Placebo-controlled, Double-blind Study of the Efficacy of MORAb-009 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer.
Status: Enrolling
Updated: 9/4/2015
Carle Clinic Assoc.
mi
from
Urbana, IL
Click here to add this to my saved trials
An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer
A Phase 2 Randomized, Placebo-controlled, Double-blind Study of the Efficacy of MORAb-009 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer.
Status: Enrolling
Updated:  9/4/2015
University of Kansas Medical Center
mi
from
Westwood, KA
An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer
A Phase 2 Randomized, Placebo-controlled, Double-blind Study of the Efficacy of MORAb-009 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer.
Status: Enrolling
Updated: 9/4/2015
University of Kansas Medical Center
mi
from
Westwood, KA
Click here to add this to my saved trials
An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer
A Phase 2 Randomized, Placebo-controlled, Double-blind Study of the Efficacy of MORAb-009 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer.
Status: Enrolling
Updated:  9/4/2015
Jayne Gurtler, MD, Laura Brinz, MD, & Angelo Russo, MD
mi
from
Metairie, LA
An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer
A Phase 2 Randomized, Placebo-controlled, Double-blind Study of the Efficacy of MORAb-009 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer.
Status: Enrolling
Updated: 9/4/2015
Jayne Gurtler, MD, Laura Brinz, MD, & Angelo Russo, MD
mi
from
Metairie, LA
Click here to add this to my saved trials
An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer
A Phase 2 Randomized, Placebo-controlled, Double-blind Study of the Efficacy of MORAb-009 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer.
Status: Enrolling
Updated:  9/4/2015
Providence Cancer Center, Oncology, Clinical Trials
mi
from
Southfield, MI
An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer
A Phase 2 Randomized, Placebo-controlled, Double-blind Study of the Efficacy of MORAb-009 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer.
Status: Enrolling
Updated: 9/4/2015
Providence Cancer Center, Oncology, Clinical Trials
mi
from
Southfield, MI
Click here to add this to my saved trials
An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer
A Phase 2 Randomized, Placebo-controlled, Double-blind Study of the Efficacy of MORAb-009 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer.
Status: Enrolling
Updated:  9/4/2015
The Center for Cancer and Hematologic Disease
mi
from
Cherry Hill, NJ
An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer
A Phase 2 Randomized, Placebo-controlled, Double-blind Study of the Efficacy of MORAb-009 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer.
Status: Enrolling
Updated: 9/4/2015
The Center for Cancer and Hematologic Disease
mi
from
Cherry Hill, NJ
Click here to add this to my saved trials
An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer
A Phase 2 Randomized, Placebo-controlled, Double-blind Study of the Efficacy of MORAb-009 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer.
Status: Enrolling
Updated:  9/4/2015
Arena Oncology Associates PC
mi
from
Lake Success, NY
An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer
A Phase 2 Randomized, Placebo-controlled, Double-blind Study of the Efficacy of MORAb-009 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer.
Status: Enrolling
Updated: 9/4/2015
Arena Oncology Associates PC
mi
from
Lake Success, NY
Click here to add this to my saved trials
An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer
A Phase 2 Randomized, Placebo-controlled, Double-blind Study of the Efficacy of MORAb-009 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer.
Status: Enrolling
Updated:  9/4/2015
Hanover Medical Specialists
mi
from
Wilmington, NC
An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer
A Phase 2 Randomized, Placebo-controlled, Double-blind Study of the Efficacy of MORAb-009 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer.
Status: Enrolling
Updated: 9/4/2015
Hanover Medical Specialists
mi
from
Wilmington, NC
Click here to add this to my saved trials
An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer
A Phase 2 Randomized, Placebo-controlled, Double-blind Study of the Efficacy of MORAb-009 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer.
Status: Enrolling
Updated:  9/4/2015
Gabrail Cancer Center
mi
from
Canton, OH
An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer
A Phase 2 Randomized, Placebo-controlled, Double-blind Study of the Efficacy of MORAb-009 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer.
Status: Enrolling
Updated: 9/4/2015
Gabrail Cancer Center
mi
from
Canton, OH
Click here to add this to my saved trials
An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer
A Phase 2 Randomized, Placebo-controlled, Double-blind Study of the Efficacy of MORAb-009 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer.
Status: Enrolling
Updated:  9/4/2015
University of Oklahoma Health Sciences Center
mi
from
Oklahoma City, OK
An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer
A Phase 2 Randomized, Placebo-controlled, Double-blind Study of the Efficacy of MORAb-009 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer.
Status: Enrolling
Updated: 9/4/2015
University of Oklahoma Health Sciences Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer
A Phase 2 Randomized, Placebo-controlled, Double-blind Study of the Efficacy of MORAb-009 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer.
Status: Enrolling
Updated:  9/4/2015
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer
A Phase 2 Randomized, Placebo-controlled, Double-blind Study of the Efficacy of MORAb-009 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer.
Status: Enrolling
Updated: 9/4/2015
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer
A Phase 2 Randomized, Placebo-controlled, Double-blind Study of the Efficacy of MORAb-009 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer.
Status: Enrolling
Updated:  9/4/2015
South Carolina Oncology Associates, PA
mi
from
Columbia, SC
An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer
A Phase 2 Randomized, Placebo-controlled, Double-blind Study of the Efficacy of MORAb-009 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer.
Status: Enrolling
Updated: 9/4/2015
South Carolina Oncology Associates, PA
mi
from
Columbia, SC
Click here to add this to my saved trials
An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer
A Phase 2 Randomized, Placebo-controlled, Double-blind Study of the Efficacy of MORAb-009 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer.
Status: Enrolling
Updated:  9/4/2015
Arlington Cancer Center
mi
from
Arlington, TX
An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer
A Phase 2 Randomized, Placebo-controlled, Double-blind Study of the Efficacy of MORAb-009 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer.
Status: Enrolling
Updated: 9/4/2015
Arlington Cancer Center
mi
from
Arlington, TX
Click here to add this to my saved trials
An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer
A Phase 2 Randomized, Placebo-controlled, Double-blind Study of the Efficacy of MORAb-009 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer.
Status: Enrolling
Updated:  9/4/2015
Baylor College of Medicine
mi
from
Houston, TX
An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer
A Phase 2 Randomized, Placebo-controlled, Double-blind Study of the Efficacy of MORAb-009 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer.
Status: Enrolling
Updated: 9/4/2015
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer
A Phase 2 Randomized, Placebo-controlled, Double-blind Study of the Efficacy of MORAb-009 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer.
Status: Enrolling
Updated:  9/4/2015
South Texas Onocology Hemotology, PA
mi
from
San Antonio, TX
An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer
A Phase 2 Randomized, Placebo-controlled, Double-blind Study of the Efficacy of MORAb-009 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer.
Status: Enrolling
Updated: 9/4/2015
South Texas Onocology Hemotology, PA
mi
from
San Antonio, TX
Click here to add this to my saved trials
An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer
A Phase 2 Randomized, Placebo-controlled, Double-blind Study of the Efficacy of MORAb-009 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer.
Status: Enrolling
Updated:  9/4/2015
Providence Western Washington Oncology
mi
from
Lacey, WA
An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer
A Phase 2 Randomized, Placebo-controlled, Double-blind Study of the Efficacy of MORAb-009 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer.
Status: Enrolling
Updated: 9/4/2015
Providence Western Washington Oncology
mi
from
Lacey, WA
Click here to add this to my saved trials
An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer
A Phase 2 Randomized, Placebo-controlled, Double-blind Study of the Efficacy of MORAb-009 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer.
Status: Enrolling
Updated:  9/4/2015
Medical College of Wisconsin - Clinical Cancer Center
mi
from
Milwaukee, WI
An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer
A Phase 2 Randomized, Placebo-controlled, Double-blind Study of the Efficacy of MORAb-009 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer.
Status: Enrolling
Updated: 9/4/2015
Medical College of Wisconsin - Clinical Cancer Center
mi
from
Milwaukee, WI
Click here to add this to my saved trials
An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer
A Phase 2 Randomized, Placebo-controlled, Double-blind Study of the Efficacy of MORAb-009 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer.
Status: Enrolling
Updated:  9/4/2015
Centre Hospitalier Jolimont-Lobbes
mi
from
Haine Saint Paul,
An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer
A Phase 2 Randomized, Placebo-controlled, Double-blind Study of the Efficacy of MORAb-009 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer.
Status: Enrolling
Updated: 9/4/2015
Centre Hospitalier Jolimont-Lobbes
mi
from
Haine Saint Paul,
Click here to add this to my saved trials
Capecitabine, Docetaxel and Gemcitabine in Patients With Advanced Pancreas Cancer
A Dose Escalating (Phase I) Study Looking at the Biomodulation of Capecitabine by Docetaxel and Gemcitabine in Patients With Advanced Pancreas Cancer
Status: Enrolling
Updated:  9/15/2015
University of Michigan Comprehensive Cancer Center
mi
from
Ann Arbor, MI
Capecitabine, Docetaxel and Gemcitabine in Patients With Advanced Pancreas Cancer
A Dose Escalating (Phase I) Study Looking at the Biomodulation of Capecitabine by Docetaxel and Gemcitabine in Patients With Advanced Pancreas Cancer
Status: Enrolling
Updated: 9/15/2015
University of Michigan Comprehensive Cancer Center
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Capecitabine, Docetaxel and Gemcitabine in Patients With Advanced Pancreas Cancer
A Dose Escalating (Phase I) Study Looking at the Biomodulation of Capecitabine by Docetaxel and Gemcitabine in Patients With Advanced Pancreas Cancer
Status: Enrolling
Updated:  9/15/2015
Ohio State University
mi
from
Columbus, OH
Capecitabine, Docetaxel and Gemcitabine in Patients With Advanced Pancreas Cancer
A Dose Escalating (Phase I) Study Looking at the Biomodulation of Capecitabine by Docetaxel and Gemcitabine in Patients With Advanced Pancreas Cancer
Status: Enrolling
Updated: 9/15/2015
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Gemcitabine, Infusional 5 Fluorouracil and Bevacizumab in Patients With Advanced Pancreas Cancer
A Phase II Study of the Combination of Fixed Dose Rate Gemcitabine, Infusional 5 Fluorouracil and Bevacizumab in Patients With Advanced Pancreas Cancer
Status: Enrolling
Updated:  9/15/2015
University of Michigan
mi
from
Ann Arbor, MI
Gemcitabine, Infusional 5 Fluorouracil and Bevacizumab in Patients With Advanced Pancreas Cancer
A Phase II Study of the Combination of Fixed Dose Rate Gemcitabine, Infusional 5 Fluorouracil and Bevacizumab in Patients With Advanced Pancreas Cancer
Status: Enrolling
Updated: 9/15/2015
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Gemcitabine, Infusional 5 Fluorouracil and Bevacizumab in Patients With Advanced Pancreas Cancer
A Phase II Study of the Combination of Fixed Dose Rate Gemcitabine, Infusional 5 Fluorouracil and Bevacizumab in Patients With Advanced Pancreas Cancer
Status: Enrolling
Updated:  9/15/2015
The Ohio State University James Cancer Hospital
mi
from
Columbus, OH
Gemcitabine, Infusional 5 Fluorouracil and Bevacizumab in Patients With Advanced Pancreas Cancer
A Phase II Study of the Combination of Fixed Dose Rate Gemcitabine, Infusional 5 Fluorouracil and Bevacizumab in Patients With Advanced Pancreas Cancer
Status: Enrolling
Updated: 9/15/2015
The Ohio State University James Cancer Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Dasatinib in Treating Patients With Stage IV Pancreatic Cancer
A Phase II Clinical Trial of Dasatinib in Patients With Metastatic Pancreatic Cancer
Status: Enrolling
Updated:  9/18/2015
City of Hope Comprehensive Cancer Center
mi
from
Duarte, CA
Dasatinib in Treating Patients With Stage IV Pancreatic Cancer
A Phase II Clinical Trial of Dasatinib in Patients With Metastatic Pancreatic Cancer
Status: Enrolling
Updated: 9/18/2015
City of Hope Comprehensive Cancer Center
mi
from
Duarte, CA
Click here to add this to my saved trials
Dasatinib in Treating Patients With Stage IV Pancreatic Cancer
A Phase II Clinical Trial of Dasatinib in Patients With Metastatic Pancreatic Cancer
Status: Enrolling
Updated:  9/18/2015
City of Hope Medical Group Inc
mi
from
Pasadena, CA
Dasatinib in Treating Patients With Stage IV Pancreatic Cancer
A Phase II Clinical Trial of Dasatinib in Patients With Metastatic Pancreatic Cancer
Status: Enrolling
Updated: 9/18/2015
City of Hope Medical Group Inc
mi
from
Pasadena, CA
Click here to add this to my saved trials
MDX-010 in Treating Patients With Stage IV Pancreatic Cancer That Cannot Be Removed By Surgery
Phase II Trial of Single Agent Ipilimumab (MDX-010 Anti CTLA-4) for Subjects With Locally Advanced or Metastatic Pancreatic Adenocarcinoma
Status: Enrolling
Updated:  9/23/2015
Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office
mi
from
Bethesda, MD
MDX-010 in Treating Patients With Stage IV Pancreatic Cancer That Cannot Be Removed By Surgery
Phase II Trial of Single Agent Ipilimumab (MDX-010 Anti CTLA-4) for Subjects With Locally Advanced or Metastatic Pancreatic Adenocarcinoma
Status: Enrolling
Updated: 9/23/2015
Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office
mi
from
Bethesda, MD
Click here to add this to my saved trials
MDX-010 in Treating Patients With Stage IV Pancreatic Cancer That Cannot Be Removed By Surgery
Phase II Trial of Single Agent Ipilimumab (MDX-010 Anti CTLA-4) for Subjects With Locally Advanced or Metastatic Pancreatic Adenocarcinoma
Status: Enrolling
Updated:  9/23/2015
NCI - Surgery Branch
mi
from
Bethesda, MD
MDX-010 in Treating Patients With Stage IV Pancreatic Cancer That Cannot Be Removed By Surgery
Phase II Trial of Single Agent Ipilimumab (MDX-010 Anti CTLA-4) for Subjects With Locally Advanced or Metastatic Pancreatic Adenocarcinoma
Status: Enrolling
Updated: 9/23/2015
NCI - Surgery Branch
mi
from
Bethesda, MD
Click here to add this to my saved trials
Studying a Tumor Marker for Testicular Cancer, Skin Cancer, Small Intestine Cancer, and Pancreatic Cancer
The Role of TAB3 Protein in Tumorigenesis
Status: Enrolling
Updated:  9/28/2015
University Hospitals Seidman Cancer Center
mi
from
Cleveland, OH
Studying a Tumor Marker for Testicular Cancer, Skin Cancer, Small Intestine Cancer, and Pancreatic Cancer
The Role of TAB3 Protein in Tumorigenesis
Status: Enrolling
Updated: 9/28/2015
University Hospitals Seidman Cancer Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Biological Markers in Patients With Pancreatic Cancer Experiencing Weight Loss
Role of Caspase-3, Phosphatidylinositol-3 Kinase (PI3K), and 3-methylhistidine (3-MH) in the Pathophysiology of Skeletal Muscle Loss in Weight-losing Pancreas Cancer Patients
Status: Enrolling
Updated:  9/29/2015
Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center
mi
from
Cleveland, OH
Biological Markers in Patients With Pancreatic Cancer Experiencing Weight Loss
Role of Caspase-3, Phosphatidylinositol-3 Kinase (PI3K), and 3-methylhistidine (3-MH) in the Pathophysiology of Skeletal Muscle Loss in Weight-losing Pancreas Cancer Patients
Status: Enrolling
Updated: 9/29/2015
Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Safety and Efficacy Study of DCVax-Direct in Solid Tumors
A PHASE I/II CLINICAL TRIAL EVALUATING DCVax-Direct, AUTOLOGOUS ACTIVATED DENDRITIC CELLS FOR INTRATUMORAL INJECTION, IN PATIENTS WITH SOLID TUMORS
Status: Enrolling
Updated:  10/6/2015
Orlando Health
mi
from
Orlando, FL
Safety and Efficacy Study of DCVax-Direct in Solid Tumors
A PHASE I/II CLINICAL TRIAL EVALUATING DCVax-Direct, AUTOLOGOUS ACTIVATED DENDRITIC CELLS FOR INTRATUMORAL INJECTION, IN PATIENTS WITH SOLID TUMORS
Status: Enrolling
Updated: 10/6/2015
Orlando Health
mi
from
Orlando, FL
Click here to add this to my saved trials
Safety and Efficacy Study of DCVax-Direct in Solid Tumors
A PHASE I/II CLINICAL TRIAL EVALUATING DCVax-Direct, AUTOLOGOUS ACTIVATED DENDRITIC CELLS FOR INTRATUMORAL INJECTION, IN PATIENTS WITH SOLID TUMORS
Status: Enrolling
Updated:  10/6/2015
M.D. Anderson Cancer Center
mi
from
Houston, TX
Safety and Efficacy Study of DCVax-Direct in Solid Tumors
A PHASE I/II CLINICAL TRIAL EVALUATING DCVax-Direct, AUTOLOGOUS ACTIVATED DENDRITIC CELLS FOR INTRATUMORAL INJECTION, IN PATIENTS WITH SOLID TUMORS
Status: Enrolling
Updated: 10/6/2015
M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Changes in Muscle Tissue in Patients With Pancreatic Cancer
Pilot Study of Changes in Fat-Free Mass in Pancreatic Carcinoma Patients
Status: Enrolling
Updated:  10/8/2015
Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center
mi
from
Cleveland, OH
Changes in Muscle Tissue in Patients With Pancreatic Cancer
Pilot Study of Changes in Fat-Free Mass in Pancreatic Carcinoma Patients
Status: Enrolling
Updated: 10/8/2015
Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Disease Management Program or Usual Care in Patients With Stage III or Stage IV Lung Cancer, Pancreatic Cancer, Ovarian Cancer, or Colorectal Cancer, and Their Caregivers
Improving the Quality of Advanced Cancer Care With Disease Management
Status: Enrolling
Updated:  10/8/2015
University Hospitals Seidman Cancer Center
mi
from
Cleveland, OH
Disease Management Program or Usual Care in Patients With Stage III or Stage IV Lung Cancer, Pancreatic Cancer, Ovarian Cancer, or Colorectal Cancer, and Their Caregivers
Improving the Quality of Advanced Cancer Care With Disease Management
Status: Enrolling
Updated: 10/8/2015
University Hospitals Seidman Cancer Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Ghrelin Levels in Pancreatic Cancer Patients
Assessment of Plasma Ghrelin Levels in Patients With Pancreatic Cancer
Status: Enrolling
Updated:  10/12/2015
Dartmouth Hitchcock Medical Center/Norris Cotton Cancer Center
mi
from
Lebanon, NH
Ghrelin Levels in Pancreatic Cancer Patients
Assessment of Plasma Ghrelin Levels in Patients With Pancreatic Cancer
Status: Enrolling
Updated: 10/12/2015
Dartmouth Hitchcock Medical Center/Norris Cotton Cancer Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
A Prospective Randomized Controlled Multicenter Study of the Effect of Dalteparin on Quality of Life in Unresectable Pancreatic Cancer
Status: Enrolling
Updated:  10/13/2015
MBCCOP - Gulf Coast
mi
from
Mobile, AL
Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
A Prospective Randomized Controlled Multicenter Study of the Effect of Dalteparin on Quality of Life in Unresectable Pancreatic Cancer
Status: Enrolling
Updated: 10/13/2015
MBCCOP - Gulf Coast
mi
from
Mobile, AL
Click here to add this to my saved trials
Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
A Prospective Randomized Controlled Multicenter Study of the Effect of Dalteparin on Quality of Life in Unresectable Pancreatic Cancer
Status: Enrolling
Updated:  10/13/2015
CCOP - Colorado Cancer Research Program, Incorporated
mi
from
Denver, CO
Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
A Prospective Randomized Controlled Multicenter Study of the Effect of Dalteparin on Quality of Life in Unresectable Pancreatic Cancer
Status: Enrolling
Updated: 10/13/2015
CCOP - Colorado Cancer Research Program, Incorporated
mi
from
Denver, CO
Click here to add this to my saved trials
Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
A Prospective Randomized Controlled Multicenter Study of the Effect of Dalteparin on Quality of Life in Unresectable Pancreatic Cancer
Status: Enrolling
Updated:  10/13/2015
MBCCOP - University of Illinois at Chicago
mi
from
Chicago, IL
Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
A Prospective Randomized Controlled Multicenter Study of the Effect of Dalteparin on Quality of Life in Unresectable Pancreatic Cancer
Status: Enrolling
Updated: 10/13/2015
MBCCOP - University of Illinois at Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
A Prospective Randomized Controlled Multicenter Study of the Effect of Dalteparin on Quality of Life in Unresectable Pancreatic Cancer
Status: Enrolling
Updated:  10/13/2015
CCOP - Central Illinois
mi
from
Decatur, IL
Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
A Prospective Randomized Controlled Multicenter Study of the Effect of Dalteparin on Quality of Life in Unresectable Pancreatic Cancer
Status: Enrolling
Updated: 10/13/2015
CCOP - Central Illinois
mi
from
Decatur, IL
Click here to add this to my saved trials
Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
A Prospective Randomized Controlled Multicenter Study of the Effect of Dalteparin on Quality of Life in Unresectable Pancreatic Cancer
Status: Enrolling
Updated:  10/13/2015
CCOP - Kalamazoo
mi
from
Kalamazoo, MI
Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
A Prospective Randomized Controlled Multicenter Study of the Effect of Dalteparin on Quality of Life in Unresectable Pancreatic Cancer
Status: Enrolling
Updated: 10/13/2015
CCOP - Kalamazoo
mi
from
Kalamazoo, MI
Click here to add this to my saved trials
Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
A Prospective Randomized Controlled Multicenter Study of the Effect of Dalteparin on Quality of Life in Unresectable Pancreatic Cancer
Status: Enrolling
Updated:  10/13/2015
CCOP - Kansas City
mi
from
Kansas City, MO
Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
A Prospective Randomized Controlled Multicenter Study of the Effect of Dalteparin on Quality of Life in Unresectable Pancreatic Cancer
Status: Enrolling
Updated: 10/13/2015
CCOP - Kansas City
mi
from
Kansas City, MO
Click here to add this to my saved trials
Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
A Prospective Randomized Controlled Multicenter Study of the Effect of Dalteparin on Quality of Life in Unresectable Pancreatic Cancer
Status: Enrolling
Updated:  10/13/2015
CCOP - Hematology-Oncology Associates of Central New York
mi
from
East Syracuse, NY
Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
A Prospective Randomized Controlled Multicenter Study of the Effect of Dalteparin on Quality of Life in Unresectable Pancreatic Cancer
Status: Enrolling
Updated: 10/13/2015
CCOP - Hematology-Oncology Associates of Central New York
mi
from
East Syracuse, NY
Click here to add this to my saved trials
Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
A Prospective Randomized Controlled Multicenter Study of the Effect of Dalteparin on Quality of Life in Unresectable Pancreatic Cancer
Status: Enrolling
Updated:  10/13/2015
University of Rochester Cancer Center CCOP Research Base
mi
from
Rochester, NY
Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
A Prospective Randomized Controlled Multicenter Study of the Effect of Dalteparin on Quality of Life in Unresectable Pancreatic Cancer
Status: Enrolling
Updated: 10/13/2015
University of Rochester Cancer Center CCOP Research Base
mi
from
Rochester, NY
Click here to add this to my saved trials
Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
A Prospective Randomized Controlled Multicenter Study of the Effect of Dalteparin on Quality of Life in Unresectable Pancreatic Cancer
Status: Enrolling
Updated:  10/13/2015
CCOP - Southeast Cancer Control Consortium
mi
from
Goldsboro, NC
Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
A Prospective Randomized Controlled Multicenter Study of the Effect of Dalteparin on Quality of Life in Unresectable Pancreatic Cancer
Status: Enrolling
Updated: 10/13/2015
CCOP - Southeast Cancer Control Consortium
mi
from
Goldsboro, NC
Click here to add this to my saved trials
Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
A Prospective Randomized Controlled Multicenter Study of the Effect of Dalteparin on Quality of Life in Unresectable Pancreatic Cancer
Status: Enrolling
Updated:  10/13/2015
CCOP - Columbus
mi
from
Columbus, OH
Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
A Prospective Randomized Controlled Multicenter Study of the Effect of Dalteparin on Quality of Life in Unresectable Pancreatic Cancer
Status: Enrolling
Updated: 10/13/2015
CCOP - Columbus
mi
from
Columbus, OH
Click here to add this to my saved trials
Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
A Prospective Randomized Controlled Multicenter Study of the Effect of Dalteparin on Quality of Life in Unresectable Pancreatic Cancer
Status: Enrolling
Updated:  10/13/2015
CCOP - Dayton
mi
from
Dayton, OH
Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
A Prospective Randomized Controlled Multicenter Study of the Effect of Dalteparin on Quality of Life in Unresectable Pancreatic Cancer
Status: Enrolling
Updated: 10/13/2015
CCOP - Dayton
mi
from
Dayton, OH
Click here to add this to my saved trials
Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
A Prospective Randomized Controlled Multicenter Study of the Effect of Dalteparin on Quality of Life in Unresectable Pancreatic Cancer
Status: Enrolling
Updated:  10/13/2015
CCOP - Greenville
mi
from
Greenville, SC
Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
A Prospective Randomized Controlled Multicenter Study of the Effect of Dalteparin on Quality of Life in Unresectable Pancreatic Cancer
Status: Enrolling
Updated: 10/13/2015
CCOP - Greenville
mi
from
Greenville, SC
Click here to add this to my saved trials
Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
A Prospective Randomized Controlled Multicenter Study of the Effect of Dalteparin on Quality of Life in Unresectable Pancreatic Cancer
Status: Enrolling
Updated:  10/13/2015
CCOP - Northwest
mi
from
Tacoma, WA
Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
A Prospective Randomized Controlled Multicenter Study of the Effect of Dalteparin on Quality of Life in Unresectable Pancreatic Cancer
Status: Enrolling
Updated: 10/13/2015
CCOP - Northwest
mi
from
Tacoma, WA
Click here to add this to my saved trials
Visceral Lymphatic Mapping Using Isosulfan Blue in Patients With Cancer of the Pancreas, Colon, Stomach, Small Intestine, or Gallbladder
Visceral Lymphatic Mapping Project: A Pilot Study
Status: Enrolling
Updated:  10/22/2015
Wake Forest University Comprehensive Cancer Center
mi
from
Winston-Salem, NC
Visceral Lymphatic Mapping Using Isosulfan Blue in Patients With Cancer of the Pancreas, Colon, Stomach, Small Intestine, or Gallbladder
Visceral Lymphatic Mapping Project: A Pilot Study
Status: Enrolling
Updated: 10/22/2015
Wake Forest University Comprehensive Cancer Center
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Gemcitabine/Abraxane Chemotherapy and Dose Escalated Radiotherapy for Locally Advanced, Unresectable Pancreatic Cancer
Gemcitabine/Abraxane Chemotherapy and Dose Escalated Radiotherapy for Locally Advanced, Unresectable Pancreatic Cancer
Status: Enrolling
Updated:  10/23/2015
University of Cincinnati
mi
from
Cincinnati, OH
Gemcitabine/Abraxane Chemotherapy and Dose Escalated Radiotherapy for Locally Advanced, Unresectable Pancreatic Cancer
Gemcitabine/Abraxane Chemotherapy and Dose Escalated Radiotherapy for Locally Advanced, Unresectable Pancreatic Cancer
Status: Enrolling
Updated: 10/23/2015
University of Cincinnati
mi
from
Cincinnati, OH
Click here to add this to my saved trials
AdV-tk Therapy With Surgery and Chemoradiation for Pancreas Cancer (PaTK01)
AdV-tk + Valacyclovir Therapy in Combination With Surgery and Chemoradiation for Pancreas Cancer
Status: Enrolling
Updated:  10/28/2015
City of Hope Medical Center
mi
from
Duarte, CA
AdV-tk Therapy With Surgery and Chemoradiation for Pancreas Cancer (PaTK01)
AdV-tk + Valacyclovir Therapy in Combination With Surgery and Chemoradiation for Pancreas Cancer
Status: Enrolling
Updated: 10/28/2015
City of Hope Medical Center
mi
from
Duarte, CA
Click here to add this to my saved trials
AdV-tk Therapy With Surgery and Chemoradiation for Pancreas Cancer (PaTK01)
AdV-tk + Valacyclovir Therapy in Combination With Surgery and Chemoradiation for Pancreas Cancer
Status: Enrolling
Updated:  10/28/2015
Scripps Green Hospital/Scripps Cancer Center
mi
from
La Jolla, CA
AdV-tk Therapy With Surgery and Chemoradiation for Pancreas Cancer (PaTK01)
AdV-tk + Valacyclovir Therapy in Combination With Surgery and Chemoradiation for Pancreas Cancer
Status: Enrolling
Updated: 10/28/2015
Scripps Green Hospital/Scripps Cancer Center
mi
from
La Jolla, CA
Click here to add this to my saved trials
AdV-tk Therapy With Surgery and Chemoradiation for Pancreas Cancer (PaTK01)
AdV-tk + Valacyclovir Therapy in Combination With Surgery and Chemoradiation for Pancreas Cancer
Status: Enrolling
Updated:  10/28/2015
Ohio State University
mi
from
Columbus, OH
AdV-tk Therapy With Surgery and Chemoradiation for Pancreas Cancer (PaTK01)
AdV-tk + Valacyclovir Therapy in Combination With Surgery and Chemoradiation for Pancreas Cancer
Status: Enrolling
Updated: 10/28/2015
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials